Concepedia
Statistics
Publications
1
Citations
62
H-Index
Active since
2021
Affiliations
The University of Texas Southwestern Medical Center(Current)
Michael Robern is an author at The University of Texas Southwestern Medical Center.
Publications per year
2021–2021
Filgotinib or lanraplenib in moderate to severe cutaneous lupus erythematosus: a phase 2, randomized, double-blind, placebo-controlled study
Victoria P. Werth, Roy Fleischmann, Michael Robern et al. · Lara D. Veeken · 2021 · 62 citations · Full text
1–1 of 1